LLY vs MSFT
Eli Lilly and Company vs Microsoft Corporation
LLY
Eli Lilly and Company
$905.13-1.88%
MSFT
Microsoft Corporation
$411.22+4.61%
Key Metrics Comparison
| LLY | Metric | MSFT |
|---|---|---|
| $905.13 | Price | $411.22 |
| $855.18B | Market Cap | $3.05TBetter |
| 39.49 | P/E Ratio | 25.75Better |
| $22.92Better | EPS | $15.97 |
| -1.88% | Day Change | +4.61%Better |
| $1133.95 | 52W High | $555.45 |
| $623.78 | 52W Low | $355.67 |
| 3,038,716 | Volume | 43,012,959Better |
| 3,126,855 | Avg Volume | 37,609,490Better |
About Eli Lilly and Company
Healthcare | Drug Manufacturers - General
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, a...
About Microsoft Corporation
Technology | Software - Infrastructure
Microsoft Corporation develops, licenses, and supports software, services, devices, and solutions worldwide. The company operates in three segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment offers Office, Exc...